BioSpace News Archive

reMYND NV, a clinical stage company tackling neurodegeneration, announces that its lead Alzheimer program ReS19-T has successfully completed its Phase 1 study.

Ipsen announced that the European Commission has approved the use of Cabometyx® as a monotherapy for the treatment of adult patients with locally advanced or metastatic differentiated thyroid carcinoma, refractory or not eligible to radioactive iodine who have progressed during or after prior systemic therapy.

Isofol Medical AB, will publish the company’s results for the first quarter of 2022 on Thursday, May 12, 2022.

Nordic Nanovector ASA announces the publication of two new research papers highlighting approaches to improve the potential therapeutic effect of its novel CD37-targeting radioimmunoconjugate Humalutin® in B-cell malignancies, such as Non-Hodgkin Lymphoma.

Agendia, Inc. announced that it will present new data at the European Society for Medical Oncology Breast Cancer Congress 2022 taking place in Berlin, Germany on May 3-5, 2022.

May 3, 2022 09:00 UTC Tubulis announced the successful completion of a €60 million Series B financing led by Andera Partners with participation from new investors Evotec and Fund+.

Lunaphore, a Swiss life sciences company developing technologies to enable spatial biology in every laboratory, announced that it has deployed its COMET™ PA instrument at Propath UK, one of Europe’s leading contract research organizations.

NanOlogy LLC, a clinical-stage interventional oncology drug company, announced that results from a clinical trial of topical submicron particle paclitaxel in cutaneous metastases of breast cancer have been published in Breast Cancer Research and Treatment.

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases, announced that the RECOVER study is progressing well and all sites in the United States have been initiated.

Arbor Biotechnologies today announced its participation in the upcoming Bank of America Global Healthcare Conference in Las Vegas, NV.